Desiree Abdurrachim1, Klaas Nicolay1, Jeanine J Prompers1
Myocardial triglyceride (TG) accumulation has been shown to be associated with the development of diabetic cardiomyopathy. Pioglitazone is one of the commonly prescribed anti-diabetic drugs; however, its effects on cardiac function and metabolism are not yet clear. In this study, the effects of pioglitazone on myocardial TG content and cardiac function were investigated in vivo in diabetic db/db mice using 1H MRS and MRI, respectively. Our findings show that db/db mice exhibit high myocardial TG content accompanied with the development of diastolic dysfunction, while pioglitazone treatment in an early stage of diabetes normalizes myocardial TG levels and prevents diastolic dysfunction.